Article
The Association and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Obstructive Sleep Apnoea: A Scoping Review
2026-08-07
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common cause of chronic liver disease, associated with the increasing prevalence of metabolic syndrome. Inflammatory and metabolic processes in MASLD may be linked to consequences of obstructive sleep apnoea (OSA), including intermittent hypoxia and fragmented sleep. However,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d41475bf-35a4-56be-b388-4c6befc10020
- DOI
- 10.21203/rs.3.rs-10616114/v1
